Long-acting nifedipine in the management of essential hypertension: a review for cardiologists
American Journal of Cardiovascular Disease · 2024 · 14 (6) · 396-413
DOI: 10.62347/rpmz6407 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Cardiovascular Disease, 2024. Verfasst von Prakash Kumar Hazra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Manipal Hospitals Dhakuria C.I.T Scheme, Gariahat Rd, Dhakuria, LXXII Block A, P-4 & 5, Kolkata, West Bengal 700029, India. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Calcium channel antagonists, specifically long-acting nifedipine formulations, play a crucial role in treating hypertension and angina. Originally used for angina, nifedipine has been widely employed as an antihypertensive medication for over 40 years. It offers rapid action and oral bioavailability with minimal maternal or fetal side effects, making it suitable for treating hypertensive crises during pregnancy. However, it can cause a sudden drop in blood pressure and tachycardia. Long-acting formulations, such as gastrointestinal therapeutic systems, gradually release nifedipine over 24 hours, mitigating these issues. This review aims to assess the clinical efficacy and safety of long-acting nifedipine formulations in managing essential hypertension, with a focus on improving blood pressure control and addressing challenges in uncontrolled and resistant hypertension. Furthermore, long-acting nifedipine provides therapeutic advantages beyond hypertension management, showing efficacy in treating comorbid conditions such as chronic kidney disease and diabetes. Global studies support its efficacy, suggesting that a shift toward the use of long-acting nifedipine can help address the global hypertension problem and enhance the quality of life for hypertensive patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Manipal Hospitals Dhakuria C.I.T Scheme, Gariahat Rd, Dhakuria, LXXII Block A, P-4 & 5, Kolkata, West Bengal 700029, India.
- Sir Ganga Ram Hospital A1, Sarhadi Gandhi Marg, Old Rajinder Nagar, Rajinder Nagar, New Delhi 110060, India.
- Desai Heart Care Clinic Level 3, Vini Elgance, Lokmanya Tilak Road, Mhatre Wadi, Borivali West, Mumbai, Maharashtra 400092, India.
- LPS Institute of Cardiology Rawatpur Road, Gol Chauraha, Rawat Pur, Kanpur, Uttar Pradesh 208019, India.
- J.B. Chemicals and Pharmaceuticals Ltd. Cnergy It Park, Unit A, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra 400025, India.
Zitieren
APA
Hazra, P. K., Mehta, A., Desai, B., Pandey, U., Mehta, K. D., Bajpai, S., & Prasad, D. (2024). Long-acting nifedipine in the management of essential hypertension: a review for cardiologists. American Journal of Cardiovascular Disease, 14(6), 396-413. https://doi.org/10.62347/rpmz6407
Vancouver
Hazra PK, Mehta A, Desai B, Pandey U, Mehta KD, Bajpai S, et al. Long-acting nifedipine in the management of essential hypertension: a review for cardiologists. American Journal of Cardiovascular Disease. 2024;14(6):396-413. doi:10.62347/rpmz6407
BibTeX
@article{Hazra2024,
author = {Hazra, Prakash Kumar and Mehta, Ashwani and Desai, Bhupen and Pandey, Umeshwar and Mehta, Kapil Dev and Bajpai, Sarita and Prasad, Deepak},
title = {Long-acting nifedipine in the management of essential hypertension: a review for cardiologists},
journal = {American Journal of Cardiovascular Disease},
year = {2024},
volume = {14},
number = {6},
pages = {396--413},
doi = {10.62347/rpmz6407}
}
EUVIMED